Patents by Inventor Alex VELDMAN

Alex VELDMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HALF-LIFE EXTENDED FACTOR FVIIA PROTEIN FOR PREVENTION AND TREATMENT OF BLEEDING AND DOSING REGIMENS THEREFOR
    Publication number: 20170042981
    Abstract: The present invention relates to dosing regimens with half-life extended Factor VIIa (FVIIa) for prophylactic and “on-demand” treatment of bleeding, as well as for preventing a bleeding episode during or after surgery in patients with congenital or acquired bleeding disorders. The present invention further relates to the use of half-life extended FVIIa for treating or preventing blood loss in patients without bleeding disorders in situations of hemorrhage, i.e., due to trauma or surgery. Another aspect of the invention is the treatment of acquired haemophilia.
    Type: Application
    Filed: March 30, 2015
    Publication date: February 16, 2017
    Applicant: CSL LIMITED
    Inventors: Debra BENSEN-KENNEDY, Alex VELDMAN, Sabine ZOLLNER, Eva HERZOG